Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.1950 (-1.98%) ($7.1950 - $7.1950) on Tue. Jul. 11, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.9% (three month average) | RSI | 44 | Latest Price | $7.1950(-1.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.4% a day on average for past five trading days. | Weekly Trend | BCRX advances 0.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(36%) BND(25%) VCIT(25%) IBB(24%) SHY(23%) | Factors Impacting BCRX price | BCRX will decline at least -1.45% in a week (0% probabilities). XLRE(-30%) XLP(-25%) SPLV(-20%) DIA(-20%) TBT(-19%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.45% (StdDev 2.9%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.29 | 5 Day Moving Average | $7.11(1.2%) | 10 Day Moving Average | $7.08(1.62%) | 20 Day Moving Average | $7.29(-1.3%) | To recent high | -18.7% | To recent low | 3.7% | Market Cap | $1.269b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |